CVS Health is a company in transition, moving away from the old pharmacy chain to an integrated healthcare giant. Read more ...

What a time it’s been for CVS Health. In the past six months alone, the company’s stock price has increased by a massive 47.6 ...

CVS Health CVS has seen its stock surge by 53.7% in 2025, fueled by a potent combination of strong operational performance ...

The pharmacy chain modestly lowered its full-year outlook ... stock pulling back in response today. Steve Symington has no position in any of the stocks mentioned. The Motley Fool recommends CVS ...

The 10x P/E ratio aligns with the stock’s last five-year average. The company reiterated its 2023 earnings outlook in the $8.50 to $8.70 range. CVS Health’s revenue of $89.8 billion in Q3 was ...

CVS stock surged Tuesday after ... after the company improved its full-year outlook and named a new chief financial officer. The pharmacy and health insurance giant said it now expects to meet ...

CVS Health CVS delivered solid third-quarter results and maintained its 2023-24 outlook. Our estimates appear near management’s near-term guidance ranges, and at first glance, our $103 fair ...

CVS Health stock (NYSE: CVS) reported its Q2 results ... Based on solid results, the company raised its full-year earnings outlook. It now expects its adjusted EPS to be between $8.40 and $8. ...

The big reason for the revised outlook is rising ... And with CVS' health insurance business, Aetna, being a key part of its operations, the stock hasn't been able to avoid the effects of that.

Although the adjusted EPS outlook for UnitedHealth ... whether investors feel strongly about the stock one way or another. In the past 3 months, CVS Health rose 6.3%, which indicates that opinion ...

As such, the Zacks rating upgrade for CVS Health is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price. The change in a company's future ...